copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Building the Firetruck After the Fire: Analyzing the US COVID-19 . . . EU Proposes the First Pharmaceutical Legislation Reforms in Two Decades EU Pharma legislation needs a makeover, but stakeholders disagree on the right approach We look at the EC's long-anticipated proposals 10 Jul 2023 Bionest
Huntingtons Disease Archives - Bionest Bionest Highlights from AAN: Part 2 We continue our report of interesting developments from the American Academy of Neurology meeting: Neuromyelytis Optica Spectrum Disorder (NMOSD) Interest in a rare disease called neuromyelytis optica spectrum disorder (NMOSD) appears to be growing
Dsuvia - Much Needed Analgesic or Potential New . . . - bionest. com Does the United States really need another opioid drug, given the enormous public health crisis of opioid addiction facing the country today? Many experts are asking this question about the FDA’s approval in November of Dsuvia (sufentinil), a powerful opioid ten times stronger than fentanyl, the drug responsible for many opioid overdose deaths in recent
Proteus Digital Health Archives - Bionest Bionest It’s a pill It’s a device It’s both FDA Approves the first Digital Drug Therapy Adherence to prescription drug therapies is a big problem, not only for patients and drug developers, but also for payers who cover the costs of such medications and then pay to treat problems the drugs were meant to prevent
Innovation takes the prize - Bionest EU Proposes the First Pharmaceutical Legislation Reforms in Two Decades EU Pharma legislation needs a makeover, but stakeholders disagree on the right approach We look at the EC's long-anticipated proposals 10 Jul 2023 Bionest
Yescarta Archives - Bionest Bionest Kite Gains First Adult CAR-T Approval Less than two weeks following the closing of Gilead’s acquisition of the company, Kite Pharma’s CAR-T immunotherapeutic, axicabtagene ciloleucel, has gained approval from the U S Food and Drug Administration as the first CAR-T therapy for an adult indication
Big Pharma Specialty Pharma Archives - Bionest Bionest GLP-1 Agonists: The Next Pharma El Dorado? – Part 1 Will GLP-1RAs ultimately succeed in the marketplace for obesity treatments, where other weight loss drugs have failed? In the first of a two-part blog series, we explore their use as a treatment of Type 2 diabetes obesity 1 May2023
cell therapy Archives - Bionest Bionest Gene Therapy for Inherited Retinal Disease Achieves a Historic Milestone This has been an amazing year in the world of drug development, with three new therapeutic classes marking historic gains We first saw Novartis’ FDA approval for the first CAR-T immunotherapy
artificial intelligence Archives - Bionest Bionest Machine Learning and Drug R D We recently wrote about the growing use of machine learning and artificial intelligence (AI) in healthcare That blog post talked primarily about the expanding applications of AI in clinical diagnostics, based on AI’s superior abilities in pattern recognition
DOES YOUR COMPANION - Bionest Bionest is a Global Consulting Firm with an Experienced Management Team Bob Easton Co-Chairman, New York